Provided is an application of a fullerene/metal-fullerene micro/ nanomaterial for preparing a pharmaceutical product. The pharmaceutical product has at least one of the following properties:1) treats a bone marrow suppression； 2) treats at least one of the following conditions caused by the bone marrow suppression: white blood cell count reduction, platedlet count reduction, hemo-globin count reduction, and monocyte count reduction； 3) protects a bone marrow cell and/or a hematopoietic cell； 4) able to build up in a bone marrow； 5)protects the liver, spleen, and kidneys； 6) removes a free radical； and 7) improves the performance of an antioxidant system in an organism.
